v3.25.3
Collaborative and Other Relationships - Summary of Activity Related To Denali Therapeutics (Details) - Research and development - Denali Therapeutics - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Collaborative arrangements and non-collaborative arrangement transactions        
Expense incurred by the collaboration $ 11.4 $ 14.9 $ 36.3 $ 44.5
Expense reflected within statements of income $ 6.9 $ 8.9 $ 21.8 $ 26.7